To include your compound in the COVID-19 Resource Center, submit it here.
Data from a single-blind, crossover, U.S. Phase I trial in 5 patients with metastatic prostate
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury